{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:05:15Z","timestamp":1790798715012,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.clnesp.2026.105129","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:02:05Z","timestamp":1790006525000},"page":"105129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Impact of use of antihypertensive drugs on resting energy expenditure and body composition: A matched-pair analysis of users and non-users"],"prefix":"10.1016","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7295-1134","authenticated-orcid":false,"given":"Sara","family":"Ramminger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens-Peter","family":"Keil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klara","family":"Jadrna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Koller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline M.","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luzia","family":"Valentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.clnesp.2026.105129_bib1","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"Mancia","year":"2023","journal-title":"J Hypertens"},{"key":"10.1016\/j.clnesp.2026.105129_bib2","series-title":"Global report on hypertension: the race against a silent killer","year":"2023"},{"issue":"11","key":"10.1016\/j.clnesp.2026.105129_bib3","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/s41569-021-00559-8","article-title":"Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension","volume":"18","author":"Zhou","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.clnesp.2026.105129_bib4","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC guidelines for the management of elevated blood pressure and hypertension","author":"McEvoy","year":"2024","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.clnesp.2026.105129_bib5","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/0026-0495(91)90053-Y","article-title":"Reduced metabolic rate during beta-adrenergic blockade in humans","volume":"40","author":"Welle","year":"1991","journal-title":"Metabolism"},{"issue":"3 Pt 2","key":"10.1016\/j.clnesp.2026.105129_bib6","first-page":"R653","article-title":"Failure of chronic beta-adrenergic blockade to inhibit overfeeding-induced thermogenesis in humans","volume":"256","author":"Welle","year":"1989","journal-title":"Am J Physiol"},{"issue":"6","key":"10.1016\/j.clnesp.2026.105129_bib7","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1054\/jcaf.2002.130238","article-title":"Effect of selective and nonselective beta-blockers on resting energy production rate and total body substrate utilization in chronic heart failure","volume":"8","author":"Podbregar","year":"2002","journal-title":"J Card Fail"},{"issue":"4","key":"10.1016\/j.clnesp.2026.105129_bib8","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1093\/ajcn\/56.4.662","article-title":"A 24-h energy expenditure study on reduced-obese and Nonobese women: effect of beta-blockade","volume":"56","author":"Buemann","year":"1992","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"10.1016\/j.clnesp.2026.105129_bib9","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00008483-200007000-00006","article-title":"The major components of human energy balance during chronic beta-adrenergic blockade","volume":"20","author":"Lamont","year":"2000","journal-title":"J Cardiopulm Rehabil"},{"issue":"5","key":"10.1016\/j.clnesp.2026.105129_bib10","doi-asserted-by":"crossref","first-page":"E740","DOI":"10.1152\/ajpendo.2001.280.5.E740","article-title":"Direct evidence for tonic sympathetic support of resting metabolic rate in healthy adult humans","volume":"280","author":"Monroe","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.clnesp.2026.105129_bib11","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1161\/01.HYP.37.2.250","article-title":"Hypothesis: beta-Adrenergic receptor blockers and weight gain: a systematic analysis","volume":"37","author":"Sharma","year":"2001","journal-title":"Hypertension"},{"issue":"6729","key":"10.1016\/j.clnesp.2026.105129_bib12","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1136\/bmj.300.6729.902","article-title":"Long term propranolol treatment and changes in body weight after myocardial infarction","volume":"300","author":"R\u00f6ssner","year":"1990","journal-title":"Br Med J"},{"issue":"1","key":"10.1016\/j.clnesp.2026.105129_bib13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2796.1994.tb01117.x","article-title":"Metabolic effects of isradipine as monotherapy or in combination with pindolol during long-term antihypertensive treatment","volume":"236","author":"Lind","year":"1994","journal-title":"J Intern Med"},{"issue":"11","key":"10.1016\/j.clnesp.2026.105129_bib14","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1038\/ijo.2010.284","article-title":"Metabolic sequelae of \u03b2-blocker therapy: weighing in on the obesity epidemic?","volume":"35","author":"Lee","year":"2011","journal-title":"Int J Obes"},{"key":"10.1016\/j.clnesp.2026.105129_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108549","article-title":"Obesity and its comorbidities, current treatment options and future perspectives: challenging bariatric surgery?","volume":"251","author":"Kloock","year":"2023","journal-title":"Pharmacol Ther"},{"issue":"2 Pt 2","key":"10.1016\/j.clnesp.2026.105129_bib16","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0002-8703(91)90451-M","article-title":"Metabolic considerations in the choice of therapy for the patient with hypertension","volume":"121","author":"Black","year":"1991","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.clnesp.2026.105129_bib17","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1161\/01.HYP.19.4.393","article-title":"Effect of antihypertensive therapy on weight loss. The trial of antihypertensive interventions and management research group","volume":"19","author":"Davis","year":"1992","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.clnesp.2026.105129_bib18","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00004872-198710000-00009","article-title":"Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial","volume":"5","author":"Wilhelmsen","year":"1987","journal-title":"J Hypertens"},{"issue":"1","key":"10.1016\/j.clnesp.2026.105129_bib19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1161\/01.HYP.36.1.26","article-title":"Resting metabolic rate and substrate use in obesity hypertension","volume":"36","author":"Kunz","year":"2000","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.clnesp.2026.105129_bib20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2125.1984.tb05021.x","article-title":"Enalapril in essential hypertension: a comparative study with propranolol. Enalapril in hypertension study group (UK)","volume":"18","author":"De Blasi","year":"1984","journal-title":"Br J Clin Pharmacol"},{"issue":"10","key":"10.1016\/j.clnesp.2026.105129_bib21","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.metabol.2008.05.019","article-title":"Effects of telmisartan on adiponectin levels and body weight in hypertensive patients with glucose intolerance","volume":"57","author":"Makita","year":"2008","journal-title":"Metabolism"},{"issue":"7","key":"10.1016\/j.clnesp.2026.105129_bib22","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1001\/archinte.1991.00400070161023","article-title":"The treatment of mild hypertension study. A randomized, placebo-controlled trial of a nutritional-hygienic regimen along with various drug monotherapies. The treatment of mild hypertension research group","volume":"151","year":"1991","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.clnesp.2026.105129_bib23","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2796.1990.tb00129.x","article-title":"The effect of captopril and metoprolol as monotherapy or combined with bendroflumethiazide on blood lipids","volume":"227","author":"Foss","year":"1990","journal-title":"J Intern Med"},{"issue":"1 Pt 1","key":"10.1016\/j.clnesp.2026.105129_bib24","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1161\/01.HYP.30.1.140","article-title":"Lisinopril versus hydrochlorothiazide in Obese hypertensive patients: a multicenter placebo-controlled trial. Treatment in obese patients with hypertension (TROPHY) study group","volume":"30","author":"Reisin","year":"1997","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/j.clnesp.2026.105129_bib25","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1111\/jch.14392","article-title":"Treatment of hypertension with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and resting metabolic rate: a cross-sectional study","volume":"23","author":"Pedrianes-Martin","year":"2021","journal-title":"J Clin Hypertens"},{"issue":"10515","key":"10.1016\/j.clnesp.2026.105129_bib26","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/S0140-6736(25)01293-0","article-title":"The effects of antidepressants on cardiometabolic and other physiological parameters: a systematic review and network meta-analysis","volume":"406","author":"Pillinger","year":"2025","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.clnesp.2026.105129_bib27","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jada.2007.01.030","article-title":"Making indirect calorimetry a gold standard for predicting energy requirements for institutionalized patients","volume":"107","author":"Schoeller","year":"2007","journal-title":"J Am Diet Assoc"},{"issue":"1","key":"10.1016\/j.clnesp.2026.105129_bib28","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-nutr-062122-031443","article-title":"Energy expenditure in humans: principles, methods, and changes throughout the life course","volume":"44","author":"Fern\u00e1ndez-Verdejo","year":"2024","journal-title":"Annu Rev Nutr"},{"issue":"9","key":"10.1016\/j.clnesp.2026.105129_bib29","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.jand.2015.04.003","article-title":"Evidence analysis library review of best practices for performing indirect calorimetry in healthy and non-critically ill individuals","volume":"115","author":"Fullmer","year":"2015","journal-title":"J Acad Nutr Diet"},{"issue":"1\u20132","key":"10.1016\/j.clnesp.2026.105129_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1113\/jphysiol.1949.sp004363","article-title":"New methods for calculating metabolic rate with special reference to protein metabolism","volume":"109","author":"Weir","year":"1949","journal-title":"J Physiol"},{"issue":"Suppl 1","key":"10.1016\/j.clnesp.2026.105129_bib31","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1038\/ejcn.2012.160","article-title":"What makes a BIA equation unique? Validity of eight-electrode multifrequency BIA to estimate body composition in a healthy adult population","volume":"67","author":"Bosy-Westphal","year":"2013","journal-title":"Eur J Clin Nutr"},{"issue":"3","key":"10.1016\/j.clnesp.2026.105129_bib32","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/ajcn\/72.3.694","article-title":"Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index","volume":"72","author":"Gallagher","year":"2000","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"10.1016\/j.clnesp.2026.105129_bib33","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/ajcn\/76.2.378","article-title":"Total-body skeletal muscle mass: estimation by a new dual-energy X-ray absorptiometry method","volume":"76","author":"Kim","year":"2002","journal-title":"Am J Clin Nutr"},{"issue":"9","key":"10.1016\/j.clnesp.2026.105129_bib34","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ejcn.2017.27","article-title":"Quantification of whole-body and segmental skeletal muscle mass using phase-sensitive 8-electrode medical bioelectrical impedance devices","volume":"71","author":"Bosy-Westphal","year":"2017","journal-title":"Eur J Clin Nutr"},{"issue":"8","key":"10.1016\/j.clnesp.2026.105129_bib35","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","article-title":"International physical activity questionnaire: 12-Country reliability and validity","volume":"35","author":"Craig","year":"2003","journal-title":"Med Sci Sports Exerc"},{"issue":"8","key":"10.1016\/j.clnesp.2026.105129_bib36","first-page":"CD009096","article-title":"Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension","volume":"2014","author":"Li","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"10.1016\/j.clnesp.2026.105129_bib37","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1073\/pnas.4.12.370","article-title":"A biometric study of human basal metabolism","volume":"4","author":"Harris","year":"1918","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.clnesp.2026.105129_bib38","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1093\/ajcn\/42.6.1170","article-title":"Human energy requirements: overestimation by widely used prediction equation","volume":"42","author":"Daly","year":"1985","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clnesp.2026.105129_bib39","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.phrs.2017.07.026","article-title":"Antihypertensive drugs","volume":"124","author":"Laurent","year":"2017","journal-title":"Pharmacol Res"},{"issue":"2","key":"10.1016\/j.clnesp.2026.105129_bib40","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/MNH.0000000000000477","article-title":"The renin-angiotensin system in the arcuate nucleus controls resting metabolic rate","volume":"28","author":"Deng","year":"2019","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"7","key":"10.1016\/j.clnesp.2026.105129_bib41","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1111\/sms.13955","article-title":"Resting metabolic rate is increased in hypertensive patients with overweight or obesity: potential mechanisms","volume":"31","author":"Pedrianes-Martin","year":"2021","journal-title":"Scand J Med Sci Sports"},{"issue":"6","key":"10.1016\/j.clnesp.2026.105129_bib42","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1042\/cs0800633","article-title":"Resting energy expenditure in chronic cardiac failure","volume":"80","author":"Riley","year":"1991","journal-title":"Clin Sci (Lond)"},{"issue":"3","key":"10.1016\/j.clnesp.2026.105129_bib43","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.tjnut.2025.01.013","article-title":"Influence of ambient temperature on resting energy expenditure in metabolically healthy males and females","volume":"155","author":"Henkel","year":"2025","journal-title":"J Nutr"},{"issue":"4","key":"10.1016\/j.clnesp.2026.105129_bib44","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1046\/j.1467-789X.2001.00044.x","article-title":"Use of beta-blockers in obesity hypertension: potential role of weight gain","volume":"2","author":"Pischon","year":"2001","journal-title":"Obes Rev"},{"issue":"4","key":"10.1016\/j.clnesp.2026.105129_bib45","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0939-4753(03)80016-9","article-title":"Effect of chronic treatment with beta-blockers on resting energy expenditure in Obese hypertensive patients during a low-calorie and physical training program","volume":"13","author":"Gondoni","year":"2003","journal-title":"Nutr Metabol Cardiovasc Dis"},{"issue":"7","key":"10.1016\/j.clnesp.2026.105129_bib46","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1751-7176.2009.00140.x","article-title":"Realities of newer beta-blockers for the management of hypertension","volume":"11","author":"Manrique","year":"2009","journal-title":"J Clin Hypertens"},{"issue":"1","key":"10.1016\/j.clnesp.2026.105129_bib47","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-2125.1996.tb00159.x","article-title":"The effect of acute vs chronic treatment with beta-adrenoceptor blockade on exercise performance, haemodynamic and metabolic parameters in healthy men and women","volume":"41","author":"Gullestad","year":"1996","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.clnesp.2026.105129_bib48","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.febslet.2004.09.027","article-title":"An angiotensin II AT1 receptor antagonist, telmisartan augments glucose uptake and GLUT4 protein expression in 3T3-L1 adipocytes","volume":"576","author":"Fujimoto","year":"2004","journal-title":"FEBS Lett"},{"issue":"10","key":"10.1016\/j.clnesp.2026.105129_bib49","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/ejcn.2015.198","article-title":"High respiratory quotient is associated with increases in body weight and fat mass in young adults","volume":"70","author":"Shook","year":"2016","journal-title":"Eur J Clin Nutr"},{"issue":"7","key":"10.1016\/j.clnesp.2026.105129_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/nu13072230","article-title":"Effect of dietary strategies on respiratory quotient and its association with clinical parameters and organ fat loss: a randomized controlled trial","volume":"13","author":"Goldenshluger","year":"2021","journal-title":"Nutrients"},{"issue":"12","key":"10.1016\/j.clnesp.2026.105129_bib51","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1038\/oby.2010.96","article-title":"Respiratory quotient predicts fat mass gain in premenopausal women","volume":"18","author":"Ellis","year":"2010","journal-title":"Obesity"},{"issue":"3","key":"10.1016\/j.clnesp.2026.105129_bib52","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000079556","article-title":"Fasting respiratory quotient as a predictor of long-term weight changes in Non-obese women","volume":"48","author":"Marra","year":"2004","journal-title":"Ann Nutr Metab"},{"issue":"6","key":"10.1016\/j.clnesp.2026.105129_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039930","article-title":"Valsartan improves adipose tissue function in humans with impaired glucose metabolism: a randomized placebo-controlled double-blind trial","volume":"7","author":"Goossens","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.clnesp.2026.105129_bib54","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2337\/dc10-2224","article-title":"Valsartan improves {beta}-cell function and insulin sensitivity in subjects with impaired glucose metabolism: a randomized controlled trial","volume":"34","author":"van der Zijl","year":"2011","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.clnesp.2026.105129_bib55","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1210\/jc.2003-032053","article-title":"Angiotensin II-induced effects on adipose and skeletal muscle tissue blood flow and lipolysis in normal-weight and obese subjects","volume":"89","author":"Goossens","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"11\u201312","key":"10.1016\/j.clnesp.2026.105129_bib56","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1055\/s-2002-38262","article-title":"Gender-specific response to interstitial angiotensin II in human white adipose tissue","volume":"34","author":"Boschmann","year":"2002","journal-title":"Horm Metab Res"},{"issue":"1","key":"10.1016\/j.clnesp.2026.105129_bib57","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1161\/01.HYP.0000042665.85720.A0","article-title":"Tissue-specific response to interstitial angiotensin II in humans","volume":"41","author":"Boschmann","year":"2003","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.clnesp.2026.105129_bib58","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1152\/physrev.00008.2024","article-title":"Sex differences in the metabolism of glucose and fatty acids by adipose tissue and skeletal muscle in humans","volume":"105","author":"Costa","year":"2025","journal-title":"Physiol Rev"},{"key":"10.1016\/j.clnesp.2026.105129_bib59","first-page":"241","article-title":"Sex-specific differences in lipid and glucose metabolism","volume":"5","author":"Varlamov","year":"2014","journal-title":"Front Endocrinol"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457726022266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457726022266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:48:19Z","timestamp":1790797699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457726022266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":59,"alternative-id":["S2405457726022266"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2026.105129","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of use of antihypertensive drugs on resting energy expenditure and body composition: A matched-pair analysis of users and non-users","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2026.105129","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of European Society for Clinical Nutrition and Metabolism.","name":"copyright","label":"Copyright"}],"article-number":"105129"}}